Kwells Kids Chewable Tablets 12 Pack
- Effective Relief From And Prevention Of Travel Sickness
- Suck, Chew Or Swallow
- Active Ingredient: Hyoscine Hydrobromide
- Buy With Confidence From UK Registered Pharmacy
- Includes Free Prescription
Motion or travel sickness is feeling sick when travelling by car, train, boat or aeroplane, or riding a fairground ride. This can make your journey or experience unpleasant. Kwells Kids Tablets contain the active ingredient hyoscine hydrobromide, which is an antimuscarinic. Kwells Kids anti-sickness medication works by correcting the body’s chemical imbalance that causes motion sickness and also by blocking messages to the brain that cause nausea. Give the recommended dosage of Kwells Kids medication to your child for fast and effective relief from nausea and effective travel sickness prevention.
What are Kwells kids travel sickness tablets used for?
Kwells kids travel sickness tablets melt in the mouth and provide fast relief from motion sickness.
The active ingredient is Hyoscine hydrobromide, this acts on the nerves that create nausea.
The active ingredient in Kwells enters the bloodstream fast due to the melt in the mouth tablets.
Tablets to be sucked, chewed or swallowed.
Tablets to be taken up to 30 minutes before the start of the journey to prevent travel sickness, or at the onset of nausea.
Children over 10: 1-2 tablets every 6 hours if required. Do not take more than 3-6 tablets in 24 hours.
Children 4-10: ½-1 tablet every 6 hours if required. Do not take more than 1½- 3 tablets in 24 hours.
See our travel sickness range.
The listed adverse drug reactions are based on spontaneous reports, thus an organization according to CIOMS II categories of frequency is not pertinent.
General: hyperthermia at high temperatures due to decreased sweating.
Eye disorders: blurred vision, mydriasis.
Gastrointestinal disorders: dry mouth.
Immune system disorders: allergic reaction and anaphylactic reaction. Hypersensitivity reactions with respective laboratory and clinical manifestations, including asthma syndrome, mild to moderate reactions affecting skin, respiratory tract, gastrointestinal tract, and cardiovascular system, and symptoms such as rash, urticaria, oedema, pruritus, cardio-respiratory distress, have been reported.
Nervous system disorders: drowsiness, dizziness, sedation and somnolence are commonly reported. Central nervous system stimulation including restlessness, hallucinations and confusion, have been less frequently reported following the administration of hyoscine.
There have been rare reports of an increase in seizure frequency in epileptic patients (the same caution for this patient population is included in Section 4.4).